BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-675X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy ; volume:25 ; number:5-6 ; day:25 ; month:4 ; year:2020 ; pages:305-320 ; date:6.2020
Apoptosis ; 25, Heft 5-6 (25.4.2020), 305-320, 6.2020
- Creator
-
Ramesh, Prashanthi
Medema, Jan Paul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10495-020-01601-9
- URN
-
urn:nbn:de:101:1-2020072819202290725151
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.200000, 12:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ramesh, Prashanthi
- Medema, Jan Paul
- SpringerLink (Online service)
Other Objects (12)
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
Bcl-B: an “unknown” protein of the Bcl-2 family
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
Thyroxine mimetics
The BCL-2 family in glioblastoma
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BCL-2 family isoforms in apoptosis and cancer
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
Early diagnostic value of Bcl-3 localization in colorectal cancer
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
BCL-2 protein family: attractive targets for cancer therapy
Bcl-2 family proteins: master regulators of cell survival
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
Bcl-B: an “unknown” protein of the Bcl-2 family
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
Thyroxine mimetics
The BCL-2 family in glioblastoma
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BCL-2 family isoforms in apoptosis and cancer
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
Early diagnostic value of Bcl-3 localization in colorectal cancer
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
BCL-2 protein family: attractive targets for cancer therapy
Bcl-2 family proteins: master regulators of cell survival
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics
Bcl-B: an “unknown” protein of the Bcl-2 family
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
Thyroxine mimetics
The BCL-2 family in glioblastoma
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BCL-2 family isoforms in apoptosis and cancer
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
Early diagnostic value of Bcl-3 localization in colorectal cancer
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
BCL-2 protein family: attractive targets for cancer therapy